What Happened
- The United States Trade Representative (USTR) confirmed that India and the US are actively progressing toward a comprehensive Bilateral Trade Agreement (BTA), building on the interim framework announced on February 6, 2026.
- Under the interim deal, India agreed to reduce tariffs on all US industrial goods and a wide range of agricultural products; the US reduced its reciprocal tariff on Indian goods from 50% to 18%.
- USTR Ambassador Greer specifically highlighted the ongoing work on "enhanced market access" — meaning India is expected to lower barriers on US goods sectors where it has historically maintained high protection, including agriculture and manufactured goods.
- India committed to purchasing $500 billion worth of US goods (energy, aircraft, technology, precious metals, coking coal) over the next five years — a commitment that would meaningfully reduce India's structural trade surplus with the US.
- Zero additional duties were secured for key Indian export categories: generic pharmaceuticals, gems and diamonds, aircraft parts, and machinery components — critical relief for Indian industry.
Static Topic Bridges
USTR: Role and Significance in US Trade Policy
The United States Trade Representative (USTR) is a cabinet-level executive branch office responsible for developing and coordinating US international trade policy, negotiating trade agreements, and representing the US in all major international trade bodies including the WTO. The USTR is the primary US government voice on trade policy, and statements by the USTR carry authoritative weight on the direction of bilateral trade negotiations. The current USTR Ambassador Jamieson Greer was confirmed in February 2025 and has been the lead negotiator of the Trump administration's "America First" trade agenda.
- USTR created in 1963 under President Kennedy; current statutory basis: Trade Act of 1974
- USTR coordinates with Commerce Department (tariff enforcement), State Department (diplomatic context), Treasury (financial market implications), and USDA (agricultural trade)
- USTR administers Section 301 investigations (unfair trade practices) and annually publishes the National Trade Estimate (NTE) report identifying foreign trade barriers — India is regularly featured
- India's 2024 NTE listing: price controls on medical devices, data localisation requirements, high import duties on agricultural goods, regulatory barriers for US financial services
- India-US Trade Policy Forum (TPF) is the primary bilateral mechanism for trade dialogue below the level of full trade negotiations
Connection to this news: The USTR's confirmation that both sides "continue to work on agreement for enhanced market access" signals that the February 2026 interim deal is explicitly a first step — the substantive negotiations on services, investment, IP, and agriculture remain ahead.
India's Goods Trade Architecture: Surplus, Barriers, and Sectoral Stakes
India's bilateral merchandise trade with the United States was approximately $130 billion in 2024-25, with India running a surplus of around $45 billion. The US is India's single largest goods export destination. India's key export categories to the US include: pharmaceuticals (generic drugs, formulations), textiles and garments, gems and jewellery, engineering goods, chemicals, and IT-enabled services (counted separately as services trade). US pressure for "enhanced market access" primarily targets India's high import duties on agricultural goods (average ~39%), automobiles, dairy, poultry, medical devices, and digital/data services.
- India-US goods trade: ~$130 billion (FY2024-25); India surplus ~$45 billion
- Top Indian exports to US: pharmaceuticals (~$8 billion), textiles (~$7 billion), gems and jewellery (~$12 billion including re-exports), engineering goods (~$7 billion)
- Top US exports to India: aircraft and parts (~$4 billion), oil and gas (~$5 billion), machinery, electronic components, agricultural products
- India's tariff on US agricultural products (avg): ~39% — compared to India's overall average applied MFN tariff of ~17-18%
- India's tariff on US automobiles: 100% (passenger cars) — a major US irritant
- India's "data localisation" policies (requiring local storage of certain data categories) are a friction point with US digital economy firms
- India's pharmaceutical sector exports $28+ billion globally; the US market accounts for ~31% of pharma exports; zero-duty access secured under the deal protects this
Connection to this news: The "enhanced market access" negotiations are asymmetric in political sensitivity: what the US seeks (agricultural, digital, automotive access) threatens politically protected Indian sectors; what India secured (pharma, gems, aircraft parts zero-duty) benefits export industries with significant employment.
India's BTA Negotiating Strategy: History and Context
India has a complex history with bilateral and multilateral trade negotiations, often balancing export-sector demands against political sensitivities in agriculture and domestic industry protection. India did not join the Regional Comprehensive Economic Partnership (RCEP) in 2020, citing concerns about Chinese import surges and inadequate protections for agriculture and services. India has active FTA negotiations with the UK (since January 2022), the EU (since June 2022), and has concluded deals with UAE (CEPA, 2022) and Australia (ECTA, 2022). The India-US BTA represents the most significant trade negotiation India has undertaken with a Western nation.
- India left RCEP negotiations in November 2019; RCEP concluded without India in November 2020 (15 nations including China, ASEAN, Japan, South Korea, Australia, New Zealand)
- India-UAE CEPA (Comprehensive Economic Partnership Agreement): signed February 18, 2022; first post-COVID bilateral FTA; reduced tariffs on 97% of Indian goods to UAE
- India-Australia ECTA (Economic Cooperation and Trade Agreement): signed April 2022; interim agreement; full CECA under negotiation
- India-UK FTA: negotiations ongoing since January 2022; stalled multiple times over services liberalisation (especially professional services and student visas)
- India-EU FTA: relaunched June 2022; issues include data flows, carbon border tax (CBAM), intellectual property, and government procurement
- The India-US BTA must cover "substantially all trade" (WTO requirement for FTA exemption from MFN) — agriculture, services, IP, investment rules all must be included
Connection to this news: India's agreement to begin BTA negotiations with the US represents a significant shift in trade posture — departing from the RCEP-era caution about comprehensive market opening toward a strategic alignment driven by geopolitical convergence with Washington.
Key Facts & Data
- India-US interim trade deal announced: February 6, 2026
- US reciprocal tariff on India: reduced from 50% to 18%
- Signing expected March 2026; operationalisation April 2026
- Zero-duty categories: generic pharmaceuticals, gems and diamonds, aircraft parts, machinery components
- India commitment: purchase $500 billion in US goods over 5 years (energy, aircraft, technology, coking coal)
- India-US goods trade: ~$130 billion (FY2024-25); India surplus ~$45 billion
- India's average applied MFN tariff: ~17-18% overall; agriculture ~39%
- India did not join RCEP (2020) — key absentee from Asia-Pacific's largest trade bloc
- India-UAE CEPA: signed February 2022 — India's most recent concluded FTA with a major partner
- India-UK FTA negotiations: ongoing since January 2022
- India-EU FTA negotiations: relaunched June 2022
- India's pharma exports to the US: ~$8 billion annually; represents ~31% of total pharma exports
- India's automobile import tariff: 100% (passenger cars)
- USTR annual NTE report regularly lists India among countries with significant trade barriers